{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:53:55Z","timestamp":1778216035004,"version":"3.51.4"},"reference-count":29,"publisher":"International Society of Global Health","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Glob Health"],"DOI":"10.7189\/jogh.16.04121","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:15:43Z","timestamp":1776975343000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparative risk of psychiatric comorbidities associated with codeine and tramadol in patients with hip osteoarthritis: a nationwide population-based cohort study"],"prefix":"10.7189","volume":"16","author":[{"given":"Yujin","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea"},{"name":"Institute of Regulatory Innovation through Science, Kyung Hee University, Seoul, Republic of Korea"},{"name":"Department of Pharmacy, College of Pharmacy and Institute of Integrated Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunjung","family":"Choo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, College of Pharmacy, Ajou University, Suwon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sooyoung","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, College of Pharmacy, Ajou University, Suwon, Republic of Korea"},{"name":"Department of Biohealth Regulatory Science, Graduate School, Ajou University, Suwon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeo Jin","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea"},{"name":"Institute of Regulatory Innovation through Science, Kyung Hee University, Seoul, Republic of Korea"},{"name":"Department of Pharmacy, College of Pharmacy and Institute of Integrated Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4223","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"key-10.7189\/jogh.16.04121-202604231802-R1","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","article-title":"Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"5","author":"GBD 2021 Osteoarthritis Collaborators","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.joca.2021.09.010","article-title":"How does hip osteoarthritis differ from knee osteoarthritis?","volume":"30","author":"Hall","year":"2022","journal-title":"Osteoarthritis Cartilage"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R3","doi-asserted-by":"publisher","first-page":"bcr2014208625","DOI":"10.1136\/bcr-2014-208625","article-title":"Hip arthritis presenting as knee pain.","volume":"2015","author":"Lam","year":"2015","journal-title":"BMJ Case Rep"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R4","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.joca.2023.05.015","article-title":"Recommendations for the management of hip and knee osteoarthritis: A systematic review of clinical practice guidelines.","volume":"31","author":"Gibbs","year":"2023","journal-title":"Osteoarthritis Cartilage"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1080\/00325481.2022.2080360","article-title":"Comparative risk-benefit profiles of weak opioids in the treatment of osteoarthritis: a network meta-analysis of randomized controlled trials.","volume":"134","author":"Li","year":"2022","journal-title":"Postgrad Med"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R6","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1017\/S0033291711002145","article-title":"Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.","volume":"42","author":"Martins","year":"2012","journal-title":"Psychol Med"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11606-013-2648-1","article-title":"Prescription opioid analgesics increase the risk of depression.","volume":"29","author":"Scherrer","year":"2014","journal-title":"J Gen Intern Med"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1370\/afm.1885","article-title":"Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations.","volume":"14","author":"Scherrer","year":"2016","journal-title":"Ann Fam Med"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R10","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.3346\/jkms.2025.40.e53","article-title":"Psychotropic drug use in Korean patients with osteoarthritis.","volume":"40","author":"Kang","year":"2025","journal-title":"J Korean Med Sci"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.amepre.2024.06.009","article-title":"Tramadol use in U.S. adults with commerical health insurance, 2005-2021.","volume":"67","author":"Basham","year":"2024","journal-title":"Am J Prev Med"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1213\/ANE.0000000000001683","article-title":"Trends in tramadol: Pharmacology, metabolism, and misuse.","volume":"124","author":"Miotto","year":"2017","journal-title":"Anesth Analg"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4093\/dmj.2020.0207","article-title":"Data configuration and publication trends for the Korean national health insurance and health insurance review & assessment database.","volume":"44","author":"Kim","year":"2020","journal-title":"Diabetes Metab J"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R15","doi-asserted-by":"crossref","unstructured":"Friedel E, Heinz A. Genetic, epigenetic, and environmental factors in serotonin-associated disease condition. In: M\u00fcller CP, Cunningham KA, editors. Handbook of Behavioral Neuroscience. Amsterdam, Netherlands: Elsevier; 2020. p. 923\u2013940.","DOI":"10.1016\/B978-0-444-64125-0.00047-5"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R16","doi-asserted-by":"publisher","first-page":"e70478","DOI":"10.1002\/brb3.70478","article-title":"Systemic inflammatory factors and neuropsychiatric disorders: A bidirectional mendelian randomization study.","volume":"15","author":"Wang","year":"2025","journal-title":"Brain Behav"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/healthcare13070837","article-title":"The Role of Neuroinflammation in the comorbidity of psychiatric disorders and internal diseases.","volume":"13","author":"C\u0103t\u0103lina","year":"2025","journal-title":"Healthcare (Basel)"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R18","doi-asserted-by":"publisher","first-page":"E194","DOI":"10.1503\/cmaj.151104","article-title":"Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports.","volume":"189","author":"Maund","year":"2017","journal-title":"CMAJ"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jpsychires.2020.02.022","article-title":"Duloxetine and cardiovascular adverse events: A systematic review and meta-analysis.","volume":"124","author":"Park","year":"2020","journal-title":"J Psychiatr Res"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R20","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.2147\/JPR.S557621","article-title":"Comparative cardiovascular safety of duloxetine and gabapentin in patients with hip osteoarthritis.","volume":"18","author":"Moon","year":"2025","journal-title":"J Pain Res"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R21","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.107.728576","article-title":"Cardiovascular effects of noncardiovascular drugs.","volume":"120","author":"Raj","year":"2009","journal-title":"Circulation"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R22","doi-asserted-by":"publisher","first-page":"e180919","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries.","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw Open"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R23","doi-asserted-by":"publisher","first-page":"e038432","DOI":"10.1136\/bmjopen-2020-038432","article-title":"Association between prescribed central nervous system depressant drugs, comorbidity and cognition among hospitalised older patients: a cross-sectional study.","volume":"10","author":"Siddiqui","year":"2020","journal-title":"BMJ Open"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.5664\/jcsm.9676","article-title":"Worsening sleep quality across the lifespan and persistent sleep disturbances in persons with opioid use disorder.","volume":"18","author":"Ellis","year":"2022","journal-title":"J Clin Sleep Med"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R25","doi-asserted-by":"publisher","first-page":"101978","DOI":"10.1016\/j.cpr.2021.101978","article-title":"Association of opioid misuse with anxiety and depression: A systematic review of the literature.","volume":"84","author":"Rogers","year":"2021","journal-title":"Clin Psychol Rev"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R26","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1001\/jama.2021.15255","article-title":"Association of tramadol vs codeine prescription dispensation with mortality and other adverse clinical outcomes.","volume":"326","author":"Xie","year":"2021","journal-title":"JAMA"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R27","doi-asserted-by":"publisher","first-page":"572083","DOI":"10.2147\/DDDT.S572083","article-title":"Psychiatric, cardiovascular and skeletal risks of codeine versus oxycodone in hip osteoarthritis: A population-based cohort study.","volume":"20","author":"Lee","year":"2026","journal-title":"Drug Des Devel Ther"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R28","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1097\/PTS.0000000000000742","article-title":"Prevalence and seriousness of analgesic-induced adverse events in Korea: A 10-year nationwide surveillance.","volume":"16","author":"Choi","year":"2020","journal-title":"J Patient Saf"},{"key":"key-10.7189\/jogh.16.04121-202604231802-R29","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1097\/PTS.0000000000000710","article-title":"The effect of opioid stewardship interventions on key outcomes: A systematic review.","volume":"16","author":"Shoemaker-Hunt","year":"2020","journal-title":"J Patient Saf"}],"container-title":["Journal of Global Health"],"original-title":[],"link":[{"URL":"https:\/\/jogh.org\/2026\/jogh-16-04121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:15:44Z","timestamp":1776975344000},"score":1,"resource":{"primary":{"URL":"https:\/\/jogh.org\/2026\/jogh-16-04121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7189\/jogh.16.04121","relation":{},"ISSN":["2047-2978","2047-2986"],"issn-type":[{"value":"2047-2978","type":"print"},{"value":"2047-2986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"04121"}}